![Colin Walsh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colin Walsh
Director/Board Member at Ceptur Therapeutics, Inc.
Colin Walsh active positions
Companies | Position | Start | End |
---|---|---|---|
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Director/Board Member | - | - |
Korro Bio, Inc.
![]() Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Director/Board Member | 2020-07-31 | - |
Element Science, Inc.
![]() Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA. | Director/Board Member | 2019-07-31 | - |
Career history of Colin Walsh
Former positions of Colin Walsh
Companies | Position | Start | End |
---|---|---|---|
Qiming US Ventures Management, LLC
![]() Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 2019-03-31 | 2023-10-30 |
ELEVATION ONCOLOGY, INC. | Director/Board Member | 2019-07-31 | 2023-09-20 |
Independent Dir/Board Member | 2019-07-31 | 2023-09-20 | |
NanoDimension, Inc. | Corporate Officer/Principal | - | - |
Training of Colin Walsh
University of California, Berkeley | Doctorate Degree |
University of Massachusetts Amherst | Undergraduate Degree |
Statistics
International
United States | 9 |
Operational
Director/Board Member | 4 |
Private Equity Investor | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ELEVATION ONCOLOGY, INC. | Health Technology |
Private companies | 5 |
---|---|
Element Science, Inc.
![]() Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA. | Electronic Technology |
Qiming US Ventures Management, LLC
![]() Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Korro Bio, Inc.
![]() Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Health Technology |
NanoDimension, Inc. | Finance |
- Stock Market
- Insiders
- Colin Walsh
- Experience